Medical Professionals/
MD Learning Channel/
MDL Genetics/

MD Learning Channel - Genetics

CME

Cancer

Cardiovascular

COVID-19

Endocrinology & Diabetes

Gastroenterology & Hepatology

Genetics

Medicine

Nephrology

Neurosciences

Obstetrics & Gynecology

Ophthalmology

Oral & Maxillofacial Surgery

Orthopaedics

Pain Management

Pulmonary, Allergy & Critical Care

Surgery

Transplant

Urology

USE OF GENETIC TESTING IN ADULT CARDIOVASCULAR DISEASES

1.00

CME/CE

MINUTES

Use of Genetic Testing in Adult Cardiovascular Diseases

Release Date:
July 12, 2022

Expiration Date:
July 11, 2025

Target Audience:
Health care professionals

Although genetic testing is becoming standard in fields such as oncology and ophthalmology, it is less common for cardiovascular diseases (CVDs)—the number one cause of death globally. Director of the UAB Cardiovascular Genomics Program Pankaj Arora, MD, FAHA, FASE, leads a discussion of the process and emerging benefits of identifying genetic risks for some of the most common CVDs, including coronary artery disease, heart failure, and arrhythmias.

He is joined by fellow program experts Ali Al-Beshri, MD, FACMG; VIbhu Parcha, MD; and Taylor McClinchey, MS, LCGC. Learn more from them about these CVD and genomics subtopics, and more:

- Monogenic and polygenic roots of different phenotypes.
- Advancements in creating polygenic risk scores (PRS) for complex diseases.
- The myriad uses of genetic analysis for diagnosis, prognosis, treatment, and prevention.
- The process of genetic counseling for patients and their families.

Take Post Test

Disclosure Information:

Planners:
Ronan O’Beirne, EdD, MBA
Director, UAB Continuing Medical Education
Katelyn Hiden
Physician Marketing Manager, UAB Health System

The planners have no relevant financial relationships with ineligible companies to disclose.

Faculty:
Pankaj Arora, MD
Director, UAB Cardiogenomics Clinic Program
Ali Al-Beshri, MD
Assistant Professor, Medical Genetics
Vibhu Parcha, MD
Resident, Internal Medicine
Taylor McClinchey, MS, CGC
Genetic Counselor II

Drs. Arora, Beshri, Parcha, and Taylor McClinchey have no financial relationships with ineligible companies related to the content of this activity to disclose.

There is no commercial support for this activity.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

PHARMACOGENOMICS: OPTIMIZING MEDICATION THERAPY

0.25

CME/CE

25 MINUTES

Pharmacogenomics: Optimizing Medication Therapy

Release Date:

May 16, 2022

Expiration Date:

May 15, 2025

Target Audience:
Health care professionals

Disclosure Information:

Planners:

Ronan O’Beirne, EdD, MBA

Director, UAB Continuing Medical Education

Katelyn Hiden

Physician Marketing Manager, UAB Health System

The planners have no relevant financial relationships with ineligible companies to disclose.

Faculty:

Nita Limdi, Pharm. D, PhD, MSPH, FAHA

Professor, Neurology & Epidemiology

Dr. Limdi has no relevant financial relationships with ineligible companies to disclose.

There is no commercial support for this activity.

Take Post Test

GENOMIC SCREENING

0.50
CME/CE

25
MINUTES

Understanding Population Genomic Screening

Release Date:

December 13, 2021

Expiration Date:

December 12, 2024

Target Audience:
Geneticists and primary care physicians

Disclosure Information:

Planners:
Ronan O’Beirne, EdD, MBA
Director, UAB Continuing Medical Education
Katelyn Hiden
Physician Marketing Manager, UAB Health System

The planners have no relevant financial relationships with ineligible companies to disclose.

Speakers:
Bruce R. Korf, MD, PhD
Chief Genomics Officer, Medical Genetics

Dr. Korf has the following financial relationships with ineligible companies:
Consulting Fee; Stock/Shareholder - Genome Medical
Honorarium; Payment for development of educational presentations; Payment for lectures, including service on speakers bureaus - Peerview, Creative Educational Concepts
Royalties - Elsevier, Wiley, UptoDate

All relevant financial relationships have been mitigated. Dr. Korf does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers (Ronan O'Beirne, EdD, and Katelyn Hiden) have any relevant financial relationships with ineligible companies to disclose.

There is no commercial support for this activity.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Take Post Test >>

GENETIC TEST RESULTS

0.25
CME/CE

17
MINUTES

Interpretation of Genetic Test Results

Release Date:
March 4, 2022

Expiration Date:
March 3, 2025

Target Audience:
Geneticists and primary care physicians

Learning Objectives: Upon completion of this CME activity, participants should be able to:

Understand how laboratories determine if genetic variants are relevant to a person's health.
Understand the modern concept of precision medicine.

Disclosure Information:

Planners:

Ronan O’Beirne, EdD, MBA

Director, UAB Continuing Medical Education

Katelyn Hiden

Physician Marketing Manager, UAB Health System

The planners have no commercial affiliations to disclose.

Faculty:

Bruce Korf, MD

Chief Genomics Officer, Professor in Medical Genetics,

Dr. Korf has the following financial relationships with ineligible companies:

Consulting Fee - GenomeMedical, SpringWorks Therapeutics

Stock/shareholder - GenomeMedical

Honorarium - PeerView CME, Creative Educational Concepts

Board membership - American College of Medical Genetics and Genomics, American Society of Human Genetics

Payment for Development of Educational Presentations - PeerView CME, Creative Educational Concepts

Royalties - Elsevier, Wiley, UpToDate

Payment for Lectures, Including Service on Speakers Bureaus - PeerView CME, Creative Educational Concepts

All relevant financial relationships have been mitigated. Dr. Korf does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers (Ronan O'Beirne, EdD and Katelyn Hiden) have any relevant financial relationships to disclose.

There is no commercial support for this activity.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Take Post Test >>

PRECISION MEDICINE

0.0
CME/CE

45
MINUTES

Medicine Grand Rounds: Precision Medicine

Release Date:
n/a

Expiration Date:
n/a

Target Audience:
Geneticists and primary care physicians.

Listen as Matt Might, PhD discusses precision medicine in a previous UAB Medicine Grand Rounds.

FAMILIAL COLORECTAL CANCER

0.0
CME/CE

13
MINUTES

Familial & Hereditary Colorectal Cancers

Familial & Hereditary Colorectal Cancers from UAB Health System on Vimeo.

Release Date:
n/a

Expiration Date:
n/a

Target Audience:
Surgeons, gastroenterologists, geneticists, and primary care physicians.

Daniel Chu, MD discusses indications for colorectal mismatch repair and genetics referrals.

Indications for Genetic Testing and Referral

0.25
CME/CE

20
MINUTES

Indications for Genetic Testing and Referral

Release Date:
August 1, 2019

Expiration Date:
August 1, 2022

Target Audience:
Genetic counselors and primary care physicians

Learning Objectives: Upon completion of this CME activity, participants should be able to:

Identify and recognize suggestive findings related to the potential for cancer predisposition.
Identify and recognize when preconception or prenatal testing may be warranted or recommended.
Identify and recognize when referrals may be warranted for evaluating rare diseases/syndromes.

Disclosure: Dr. Hurst has the following financial relationships with commercial interests:

Grants/Research Support/Grants Pending - NIH, State of Alabama, Children's of Alabama
Support for travel to meetings or other purposes - Travel for meetings from Facial Dysmorphology Analysis

Dr. Hurst does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers have any relevant financial relationships to disclose.

Accreditation Statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Take Test Now >>

What Are the Roles of Medical Geneticists and Genetic Counselors?

0.25
CME/CE

13
MINUTES

What Are the Roles of Medical Geneticists and Genetic Counselors?

Release Date:
August 1, 2019
Reissue Date:
November 11, 2022

Expiration Date:
November 10, 2022

Target Audience:
Genetic counselors and primary care physicians

Learning Objectives: Upon completion of this CME activity, participants should be able to:

Understand the role of two of the most common professionals you may encounter as a physician in clinical settings.
Understand when the integration of clinical patient assessment and genomic testing may be warranted and the importance of anticipating areas of challenge for patients and families.

Disclosure: The planners have no relevant financial relationships with ineligible companies to disclose.

Planners:

Ronan O’Beirne, EdD, MBA

Director, UAB Continuing Medical Education

Katelyn Hiden

Physician Marketing Manager, UAB Health System

Faculty:

Anna Hurst, MD

Associate Professor in Medical Genetics

Dr. Hurst has the following financial relationships with ineligible companies:

Grants/Research Support/Grants Pending - Alabama Genomic Health Initiative
Consulting Fee - CFD Research

All relevant financial relationships have been mitigated. Dr. Hurst does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers have any relevant financial relationships with ineligible companies to disclose.

There is no commercial support for this activity.

Accreditation statement: The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this online enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Take Test Now >>